BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22114829)

  • 1. Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma.
    Lin YT; Liu CJ; Chen TJ; Chen TL; Yeh YC; Wu HS; Tseng CP; Wang FD; Tzeng CH; Fung CP
    Am J Med; 2011 Dec; 124(12):1158-64. PubMed ID: 22114829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
    Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
    Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and prognostic factors of patients with pyogenic liver abscess requiring intensive care.
    Chen W; Chen CH; Chiu KL; Lai HC; Liao KF; Ho YJ; Hsu WH
    Crit Care Med; 2008 Apr; 36(4):1184-8. PubMed ID: 18379245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyogenic liver abscess as the first manifestation of hepatobiliary malignancy.
    Chong VH; Lim KS
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):547-50. PubMed ID: 19822502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
    Hwang JC; Weng SF; Weng RH
    Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
    Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
    Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
    Stuart KE; Anand AJ; Jenkins RL
    Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyogenic liver abscess as endemic disease, Taiwan.
    Tsai FC; Huang YT; Chang LY; Wang JT
    Emerg Infect Dis; 2008 Oct; 14(10):1592-600. PubMed ID: 18826824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
    Azzaroli F; Colecchia A; Lodato F; Trerè D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
    Aliment Pharmacol Ther; 2006 Jul; 24(1):129-36. PubMed ID: 16803611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with treatment failure of percutaneous catheter drainage for pyogenic liver abscess in patients with hepatobiliary-pancreatic cancer.
    Lai KC; Cheng KS; Jeng LB; Huang CC; Lee YT; Chang HR; Chen CC; Chen SC; Lee MC
    Am J Surg; 2013 Jan; 205(1):52-7. PubMed ID: 22794706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APACHE II score and primary liver cancer history had risk of hospital mortality in patients with pyogenic liver abscess.
    Hsieh CB; Tzao C; Yu CY; Chen CJ; Chang WK; Chu CH; Chou SJ; Tung HJ; Yu JC
    Dig Liver Dis; 2006 Jul; 38(7):498-502. PubMed ID: 16702033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
    Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
    Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.